Antithrombotic nipecotamide increases cyclic AMP levels and inhibits protein phosphorylation in human platelets
- 1 July 1995
- journal article
- Published by Elsevier in Life Sciences
- Vol. 57 (10) , 983-988
- https://doi.org/10.1016/0024-3205(95)02033-f
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Design and Synthesis of Piperidine-3-carboxamides as Human Platelet Aggregation InhibitorsJournal of Medicinal Chemistry, 1995
- Antiplatelet Activity of Nipecotamides in Experimental Thrombosis in MiceJournal of Pharmaceutical Sciences, 1994
- Molecular determinants of the platelet aggregation inhibitory activity of carbamoylpiperidinesJournal of Medicinal Chemistry, 1992
- Molecular mechanisms of platelet activation.Physiological Reviews, 1989
- Anagrelide: A potent and selective inhibitor of platelet cyclic AMP phosphodiesterase enzyme activityBiochemical Pharmacology, 1988
- INOSITOL TRISPHOSPHATE AND DIACYLGLYCEROL: TWO INTERACTING SECOND MESSENGERSAnnual Review of Biochemistry, 1987
- The Metabolism of Phosphoinositide-Derived Messenger MoleculesScience, 1986
- Studies and Perspectives of Protein Kinase CScience, 1986
- Cyclic nucleotides control a system which regulates Ca2+ sensitivity of platelet secretionNature, 1984
- [30] Assay of cyclic nucleotide phosphodiesterases with radioactive substratesPublished by Elsevier ,1974